By NHI Mgmt Group Editorial TeamBased on Ordr: “Medical Device Breach Statistics 2026 Report” (April 3, 2026)

TL;DR: Ordr reports that connected medical devices are expanding healthcare's attack surface, with 99% of hospitals managing at least one IoMT device with a known exploited vulnerability, 60% of devices end-of-life, and 77% of healthcare organisations targeted by ransomware in 2024. Clinical uptime is now inseparable from device visibility, segmentation, and risk-based remediation.


At a glance

What this is: Connected medical devices are creating a larger healthcare attack surface, with the source highlighting widespread known exploited vulnerabilities, end-of-life systems, and ransomware pressure across clinical environments.

Why it matters: Healthcare security teams need governance that accounts for unmanaged device identity, exposure, and segmentation because patient care can be disrupted long before conventional endpoint controls can respond.

By the numbers:

  • 99% of hospitals manage at least one IoMT device with a known exploited vulnerability.
  • 60% of medical devices are end-of-life with no available security patches.
  • 77% of healthcare organizations were targeted by ransomware in 2024.

Context

Medical device security is now a governance problem as much as a technical one. Hospitals connect more infusion pumps, imaging systems, monitors, and building systems to clinical networks, but many of those assets were never designed for modern authentication, patching, or endpoint tooling. In healthcare, the control failure is not simply exposure, it is the inability to manage device identity, lifecycle, and segmentation without interrupting patient care.

The article's core point is that IoMT risk is systemic rather than isolated. When devices run unsupported operating systems, use default credentials, or stay internet-exposed, conventional enterprise controls lose effectiveness. That creates a genuine intersection with identity and access governance because device trust, network privilege, and lifecycle ownership all become part of the security model.


Key questions

Q: What breaks when medical devices stay on flat, unsegmented networks?

A: Flat networks let a compromise in one device class spread into imaging, patient monitoring, or building systems much faster. In healthcare, that increases the chance of lateral movement, service interruption, and patient diversion. Segmentation limits blast radius and gives security teams a way to contain devices that cannot be fully hardened.

Q: Why do unsupported medical devices create such high operational risk?

A: Unsupported devices cannot receive timely security fixes, so known vulnerabilities remain exploitable for long periods. In a hospital, that matters because many of those assets are operationally essential and cannot be taken offline quickly. The result is a persistent exposure that has to be managed with containment and formal risk acceptance.

Q: How should healthcare teams prioritise medical device remediation?

A: Prioritise devices by clinical criticality, internet exposure, vulnerability status, and whether the system can be isolated without disrupting care. A vulnerable imaging system connected to core workflows deserves faster attention than a low-impact asset with the same CVE count. Effective prioritisation follows patient-safety impact, not just technical score.

Q: Who should be accountable for securing connected medical devices across their lifecycle?

A: Accountability should be shared, but not blurred. Healthcare security teams, clinical operators, and medical device manufacturers all have defined roles. Providers must enforce onboarding, monitoring, and credential discipline. Manufacturers must build secure-by-design devices with unique identities and signed firmware. When ownership is unclear, gaps appear at the handoff points where breaches most often start.


Technical breakdown

Why IoMT devices create a persistent exposure layer

Internet of Medical Things devices are not just endpoints. They are specialised systems that often need to remain available, communicate with fixed controllers, and operate for years after mainstream support ends. That combination creates persistent exposure: long device lifecycles, limited patch windows, and weak authentication controls. In practice, security teams are dealing with assets that cannot absorb the same scanning, agent deployment, or rapid remediation model used in enterprise IT. The technical problem is compounded when devices are internet-facing or sit on flat networks that allow lateral movement.

Practical implication: inventory clinical devices by exposure, support status, and trust zone before treating them like ordinary managed endpoints.

Why default credentials and unsupported operating systems matter

Weak default credentials and unsupported operating systems turn device availability into a security liability. A device that cannot receive security updates, or that still uses factory credentials, remains exploitable even when the underlying vulnerability is already known. That is especially dangerous in healthcare because the attacker does not need to compromise every device type to create impact. One vulnerable imaging system, pump, or controller can become the foothold that leads into broader clinical disruption. This is a classic lifecycle and access-control failure, not a one-off hygiene issue.

Practical implication: prioritise credential replacement and compensating controls for unsupported devices that cannot be patched.

How segmentation changes the risk model for clinical networks

Safe segmentation is the main architectural control that changes the risk profile when devices cannot be fully hardened. Segmentation limits where a compromised device can communicate, reducing the chance that a foothold in one clinical or building system becomes lateral movement into radiology, records, or operational technology. The key is to validate behaviour before enforcement, because hospital environments include fragile devices that can break under aggressive policy changes. In other words, the control is not just network isolation, it is controlled trust reduction across device classes and workflows.

Practical implication: test segmentation policies against observed device behaviour before enforcing them in production clinical networks.


Threat narrative

Attacker objective: The objective is to gain a durable foothold in healthcare infrastructure that can be used for disruption, extortion, or lateral movement into higher-value clinical systems.

  1. Entry typically begins through an exposed or weakly protected medical or building system, such as an internet-facing controller or a device with default credentials.
  2. Attackers then abuse the device's limited authentication and patching controls to maintain access and move through the network using adjacent trust relationships.
  3. Once inside, they pivot into imaging, operational, or clinical environments to interrupt care delivery, reroute patients, or support ransomware activity.
  • Azure Key Vault Contributor escalation 2024: Datadog found Azure Key Vault Contributor could add itself to access policies and read every secret, key and certificate in a vault.
  • Sisense breach 2024: A credential in Sisense's GitLab reportedly opened S3 buckets of customer tokens, passwords and certificates; CISA urged a full reset.

Read and download The State of NHI & AI Agent Breach Report 2026, covering 200+ breaches impacting Non-Human Identities including AI Agents.


NHI Mgmt Group analysis

Medical device security is now an access-governance problem, not just a visibility problem. Hospitals do not merely need to know what is on the network. They need to know which devices can be trusted, which cannot be patched, and which must be contained rather than remediated. The governance gap is lifecycle ownership, because unmanaged device trust becomes an open path into clinical operations.

End-of-life medical devices create security debt that cannot be paid down with standard endpoint controls. When 60% of devices have no available patches, the programme question changes from prevention to containment. That means segmentation, compensating controls, and risk acceptance decisions become the real control plane. Practitioners should treat unsupported clinical devices as long-term governance exceptions, not temporary gaps.

Clinical blast-radius control: the decisive control is not whether a device is vulnerable, but how far compromise can travel from that device. Medical environments are especially sensitive to lateral movement because downtime affects patient safety, operations, and neighbouring hospitals. That makes containment architecture, not simple vulnerability counting, the metric that matters most. Practitioners should measure how quickly a compromised device can be isolated from the rest of the clinical environment.

Device identity must be managed as part of healthcare cyber resilience. The article shows why conventional identity assumptions break when systems cannot support normal agents, scans, or rapid patch cycles. In this setting, identity governance extends to asset identity, network identity, and trust zone assignment. Practitioners should align security ownership with the devices that can actually be controlled, not the ones that are easiest to enumerate.

Healthcare's most exposed systems are often the least governable. Imaging systems, pumps, monitors, and OT controllers may be mission-critical, but they are frequently trapped between clinical uptime demands and outdated security design. That tension is now a board-level issue because it affects patient outcomes, operational continuity, and breach cost. Practitioners should treat medical device security as operational resilience work, not as a side project in infrastructure security.

What this signals

Clinical blast-radius control: healthcare programmes should treat segmentation as a resilience control, not just a network design choice. The point is to keep a vulnerable pump, monitor, or imaging system from becoming the entry point to wider operational disruption.

Medical device governance now has to include lifecycle status, exposure, and ownership in the same view. When devices are end-of-life or cannot support agents, teams need compensating controls and exception handling rather than pretending those assets fit standard enterprise management.

Healthcare security leaders should expect risk reduction to come from controlled containment, not from trying to force every device into the same remediation model. That shift changes how remediation backlogs, downtime risk, and patient-safety exceptions are prioritised.


For practitioners

  • Inventory device exposure by clinical function Classify medical, IoMT, IT, and OT assets by manufacturer, operating system, internet exposure, and support status so remediation can follow clinical criticality rather than raw vulnerability counts.
  • Replace factory credentials on all reachable devices Prioritise devices still using weak or default credentials, especially those that cannot run endpoint agents or modern authentication controls, because credential reset is often the only immediate access barrier.
  • Build compensating controls for end-of-life systems Use segmentation, restricted communication paths, and monitored exceptions for unsupported devices that cannot be patched, and document the residual risk as a governance decision.
  • Validate segmentation before enforcement Test network segmentation policies against observed device behaviour in staging or limited rollout so critical clinical workflows are not disrupted when rules go live.
  • Track recovery impact alongside technical exposure Measure how a device compromise would affect emergency routing, radiology, and patient throughput so remediation priority reflects operational blast radius, not only CVE severity.

Key takeaways

  • Connected medical devices expand healthcare's attack surface because many of them remain exposed, unsupported, or weakly authenticated.
  • The article's figures show a high-risk environment, including widespread known exploited vulnerabilities, end-of-life devices, and ransomware targeting.
  • Hospitals need segmentation, lifecycle governance, and compensating controls because conventional endpoint-first security does not fit many clinical devices.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

OWASP Non-Human Identity Top 10 and MITRE ATT&CK address the attack and risk surface, while NIST CSF 2.0, CIS Controls v8 and CSA Cloud Controls Matrix set the governance and control requirements practitioners need to meet.

FrameworkControl / ReferenceRelevance
OWASP Non-Human Identity Top 10NHI-06 — Insecure Cloud Deployment ConfigurationsConnected medical devices often fail secure deployment and isolation assumptions in clinical networks.
Recommendation — Map exposed medical devices to NHI-06 style isolation gaps and contain them in restricted trust zones.
NIST CSF 2.0PR.AA-05 — Access Permissions, Entitlements and AuthorizationsDevice access and network trust boundaries need explicit authorization in hospital environments.
Recommendation — Apply PR.AA-05 to enforce least-privilege communication paths for connected medical and OT devices.
CIS Controls v8CIS-5 — Account ManagementDefault credentials and unmanaged device accounts are central weaknesses in the article.
Recommendation — Use CIS-5 to inventory and remove default or stale device accounts across clinical systems.
MITRE ATT&CKTA0001;TA0008 — Initial Access; Lateral MovementThe article describes footholds through exposed devices and movement into clinical networks.
Recommendation — Map exposed medical device paths to TA0001 and TA0008 to prioritise containment controls.
CSA Cloud Controls MatrixIAM — Identity and Access ManagementCloud-style trust and authorization concepts apply to device and network access governance here.
Recommendation — Use IAM domain controls to define and enforce trust boundaries for connected medical assets.

Key terms

  • Internet of Medical Things: Internet of Medical Things, or IoMT, refers to connected medical devices that exchange data with hospital systems, cloud services, or patient monitoring platforms. These devices create both clinical value and security risk because they depend on identity, connectivity, and lifecycle control to operate safely over time.
  • Known Exploited Vulnerability: A Known Exploited Vulnerability is a flaw that has confirmed active exploitation in the wild and is tracked for urgent remediation. In governance terms, KEV status turns patching from a general hygiene task into a time-bound operational obligation.
  • Blast Radius: The potential scope of damage if a specific credential or identity is compromised. Identities with broad permissions have a larger blast radius and represent a higher priority for least-privilege enforcement and security controls.
  • Compensating Control: A compensating control is a measure that reduces risk when the ideal fix, such as immediate patching or redesign, is not possible. In OT, compensating controls often include session recording, access restriction, and tighter monitoring. They do not eliminate the underlying issue, but they narrow exposure until safer remediation can happen.

Deepen your knowledge

NHI Mgmt Group covers identity security, NHI governance, and agentic AI through independent research, practitioner guides, and the NHI Foundation Level course. It is designed for practitioners who need to connect identity governance to the broader security decisions that shape resilience.
NHIMG Editorial Note
Published by the NHIMG editorial team on October 16, 2026.
NHI Mgmt Group, the independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org